SmediCare: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SmediCare
Largest movements
- Current investments +€96,000
up €96,000 (+304%), from €31,629 to €127,629
- Cash +€11,592
up €11,592 (+63.5%), from €18,258 to €29,850
mainly Net result for the year (+€75,840) and Other debts (+€23,857)
- Tangible fixed assets -€2,070
down €2,070 (-10.2%), from €20,357 to €18,287
of which Other tangible fixed assets: -€1,243
- Profit (loss) carried forward +€75,040
up €75,040 (+153%), from €48,946 to €123,986
- Other debts +€23,857
up €23,857 (+776%), from €3,075 to €26,932
- Tax, wage and social debts +€5,434
up €5,434 (+34.3%), from €15,845 to €21,279
- Gross operating margin +€32,005
up €32,005 (+51.0%), from €62,781 to €94,786
- Taxes +€6,616
up €6,616 (+50.9%), from €13,007 to €19,623
- Financial income +€3,600
new in 2025: €3,600
- Depreciation +€1,256
up €1,256 (+154%), from €815 to €2,070
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €72,036 | €176,213 | +€104,177 | +145% |
| Fixed assets | 21/28 | €20,357 | €18,287 | -€2,070 | -10.2% |
| Tangible fixed assets | 22/27 | €20,357 | €18,287 | -€2,070 | -10.2% |
| Plant, machinery and equipment | 23 | €1,730 | €1,351 | -€380 | -21.9% |
| Furniture and vehicles | 24 | €6,469 | €6,022 | -€447 | -6.9% |
| Other tangible fixed assets | 26 | €12,158 | €10,915 | -€1,243 | -10.2% |
| Current assets | 29/58 | €51,678 | €157,926 | +€106,248 | +206% |
| Current investments | 50/53 | €31,629 | €127,629 | +€96,000 | +304% |
| Cash at bank and in hand | 54/58 | €18,258 | €29,850 | +€11,592 | +63.5% |
| Deferred charges and accrued income | 490/1 | €1,791 | €446 | -€1,345 | -75.1% |
| Total equity and liabilities | 10/49 | €72,036 | €176,213 | +€104,177 | +145% |
| Equity | 10/15 | €52,946 | €127,986 | +€75,040 | +142% |
| Contributions | 10/11 | €4,000 | €4,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €48,946 | €123,986 | +€75,040 | +153% |
| Amounts payable | 17/49 | €19,089 | €48,227 | +€29,137 | +153% |
| Amounts payable within one year | 42/48 | €19,089 | €48,227 | +€29,137 | +153% |
| Trade debts | 44 | €170 | €16 | -€154 | -90.7% |
| Suppliers | 440/4 | €170 | €16 | -€154 | -90.7% |
| Taxes, remuneration and social security | 45 | €15,845 | €21,279 | +€5,434 | +34.3% |
| Taxes | 450/3 | €15,845 | €21,279 | +€5,434 | +34.3% |
| Other amounts payable | 47/48 | €3,075 | €26,932 | +€23,857 | +776% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €815 | €2,070 | +€1,256 | +154% |
| Gross operating margin | 9900 | €62,781 | €94,786 | +€32,005 | +51.0% |
| Operating profit (loss) | 9901 | €61,966 | €92,716 | +€30,749 | +49.6% |
| Financial income | 75/76B | - | €3,600 | +€3,600 | |
| Recurring financial income | 75 | - | €3,600 | +€3,600 | |
| Financial charges | 65/66B | €13 | €852 | +€839 | +6,456% |
| Recurring financial charges | 65 | €13 | €852 | +€839 | +6,456% |
| Profit (loss) for the period before taxes | 9903 | €61,953 | €95,463 | +€33,510 | +54.1% |
| Income taxes | 67/77 | €13,007 | €19,623 | +€6,616 | +50.9% |
| Profit (loss) for the period | 9904 | €48,946 | €75,840 | +€26,894 | +54.9% |
| Profit (loss) for the period to be appropriated | 9905 | €48,946 | €75,840 | +€26,894 | +54.9% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.